Watson Laboratories Inc recalls Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15

Recalled August 8, 2012 · FDA recall D-1436-2012 · Watson Laboratories

Hazard

Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities. · FDA Class III

Units

18,938 cartons

Sold at

Nationwide.

Description

Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.

Product

Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880.

Manufacturer(s)

Watson Laboratories Inc

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →